The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a service contract for the Illumina NextSeq 2000 sequencer under the Silver Support Plan. This contract, which is set for renewal, requires comprehensive service coverage including OEM parts, labor, travel, reagent replacement upon hardware failures, and remote technical support, ensuring the continuity of critical laboratory experiments. The service is essential to maintain the functionality of the sequencer and to avoid introducing variables that could compromise ongoing research. Interested vendors must submit capability statements and relevant documentation by 10:00 am EST on March 31, 2025, via the NIAID electronic Simplified Acquisition Submission System (eSASS), with the contract period running from April 14, 2025, to April 13, 2026. For further inquiries, contact Rita Davis at rita.davis@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.